Patents by Inventor Gunnar Aberg

Gunnar Aberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING INFLAMMATORY AND/OR ALLERGIC DISORDERS WITH NORKETOTIFEN
    Publication number: 20250186421
    Abstract: The methods disclosed herein relate to methods of orally administering norketotifen to human subjects. Oral norketotifen can be administered with food to reduce nausea and vomiting in the human subject. Oral norketotifen can be coadministered with additional medications such as dupilumab or crisaborole, or it can be administered after discontinuation of dupilumab or crisaborole.
    Type: Application
    Filed: February 24, 2025
    Publication date: June 12, 2025
    Applicant: Bridge Pharma, Inc.
    Inventors: Gunnar Aberg, Kresimir Pucaj
  • Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
    Patent number: 8062627
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
    Type: Grant
    Filed: March 13, 2008
    Date of Patent: November 22, 2011
    Assignee: Sunovion Pharmaceuticals Inc.
    Inventors: Gunnar Aberg, John Morley
  • S-Isomer of 2- piperidine and Other Dermal Anesthetic Agents
    Publication number: 20100179114
    Abstract: The present invention relates to the S-isomers of anesthetic compounds, the methods of treatment therewith, the compounds being useful for inducing local anesthesia, analgesia and sleep.
    Type: Application
    Filed: March 4, 2010
    Publication date: July 15, 2010
    Applicant: BRIDGE PHARMA, INC.
    Inventors: Gunnar Aberg, Jan L. Chen
  • Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
    Patent number: 7718674
    Abstract: The present invention relates to the S-isomers of anesthetic compounds, the methods of treatment therewith, the compounds being useful for inducing local anesthesia, analgesia and sleep.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: May 18, 2010
    Assignee: Bridge Pharma, Inc.
    Inventor: Gunnar Aberg
  • METHODS AND COMPOSITIONS FOR TREATING PULMONARY DISORDERS USING OPTICALLY PURE (R,R)-FORMOTEROL
    Publication number: 20080161411
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
    Type: Application
    Filed: March 13, 2008
    Publication date: July 3, 2008
    Applicant: SEPRACOR INC.
    Inventors: Gunnar ABERG, John MORLEY
  • Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
    Patent number: 7368120
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: May 6, 2008
    Assignee: Sepracor Inc.
    Inventors: Gunnar Aberg, John Morley
  • S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
    Publication number: 20060079559
    Abstract: The present invention relates to the S-isomers of anesthetic compounds, the methods of treatment therewith, the compounds being useful for inducing local anesthesia, analgesia and sleep.
    Type: Application
    Filed: September 27, 2005
    Publication date: April 13, 2006
    Applicant: Bridge Pharma, Inc.
    Inventors: Gunnar Aberg, Jan Chen
  • R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
    Publication number: 20060079558
    Abstract: The present invention relates to the R-isomers of anesthetic compounds, the methods of treatment therewith, the compounds being useful for inducing local anesthesia, analgesia and sleep.
    Type: Application
    Filed: September 27, 2005
    Publication date: April 13, 2006
    Applicant: Bridge Pharma. Inc.
    Inventors: Gunnar Aberg, Jan Chen
  • Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
    Publication number: 20050131072
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
    Type: Application
    Filed: January 31, 2005
    Publication date: June 16, 2005
    Applicant: Sepracor Inc.
    Inventors: Gunnar Aberg, John Morley
  • Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
    Patent number: 6866839
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
    Type: Grant
    Filed: June 9, 2003
    Date of Patent: March 15, 2005
    Assignee: Sepracor Inc.
    Inventors: Gunnar Aberg, John Morley
  • Methods and compositions for treating pulmonary disorders using optically pure (R,R) -formoterol
    Publication number: 20030203970
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
    Type: Application
    Filed: June 9, 2003
    Publication date: October 30, 2003
    Applicant: Sepracor Inc.
    Inventors: Gunnar Aberg, John Morley
  • Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol
    Patent number: 6589508
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, having a low incidence of the development of tolerance and having increased duration of action.
    Type: Grant
    Filed: August 9, 2001
    Date of Patent: July 8, 2003
    Assignee: Sepracor Inc.
    Inventors: Gunnar Aberg, John Morley
  • S(?)-tolterodine in the treatment of urinary and gastrointestinal disorders
    Patent number: 6310103
    Abstract: The S-isomer of a compound represented by the following formula: and pharmaceutically acceptable salts thereof is disclosed as being useful for treating urinary disorders, including urinary incontinence, and gastrointestinal disorders, including gastrointestinal hyperativity.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: October 30, 2001
    Assignee: Bridge Pharma, Inc.
    Inventor: Gunnar Aberg
  • Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
    Patent number: 6299863
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, having a low incidence of the development of tolerance and having increased duration of action.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: October 9, 2001
    Assignee: Sepracor Inc.
    Inventors: Gunnar Aberg, John Morley
  • Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol
    Patent number: 6068833
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, having a low incidence of the development of tolerance and having increased duration of action.
    Type: Grant
    Filed: August 18, 1998
    Date of Patent: May 30, 2000
    Assignee: Sepracor Inc.
    Inventors: Gunnar Aberg, John Morley
  • NSAID/fluoride periodontal compositions and methods
    Patent number: 5807541
    Abstract: A method for preventing dental caries by administering fluoride and, at the same time controlling periodontal bone loss precipitated by the fluoride, by providing a combination of fluoride and NSAID is disclosed. Topical medicament compositions including NSAIDS and fluoride are also disclosed.
    Type: Grant
    Filed: April 22, 1996
    Date of Patent: September 15, 1998
    Assignee: Sepracor, Inc.
    Inventors: Gunnar Aberg, Thomas Patrick Jerussi, John R. McCullough
  • Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
    Patent number: 5795564
    Abstract: A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, having a low incidence of the development of tolerance and having increased bronchial distribution when administered by inhalation.
    Type: Grant
    Filed: March 7, 1996
    Date of Patent: August 18, 1998
    Assignee: Sepracor, Inc.
    Inventors: Gunnar Aberg, John Morley
  • Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
    Patent number: 5736577
    Abstract: A method for treating urinary incontinence while avoiding concomitant liability of adverse effects associated with racemic oxybutynin is disclosed. The method comprises administering a therapeutically effective amount of (S)-oxybutynin, or a pharmaceutically acceptable salt thereof, substantially free of its R enantiomer. Pharmaceutical compositions comprising (S)-oxybutynin, or a pharmaceutically acceptable salt thereof, substantially free of its R enantiomer, and a pharmaceutically acceptable carrier are also disclosed.
    Type: Grant
    Filed: June 28, 1996
    Date of Patent: April 7, 1998
    Assignee: Sepracor, Inc.
    Inventors: Gunnar Aberg, John R. McCullough
  • Treating urinary incontinence using (S)-desethyloxybutynin
    Patent number: 5677346
    Abstract: A method for treating urinary incontinence while avoiding concomitant liability of adverse effects associated with racemic oxybutynin is disclosed. The method comprises administering a therapeutically effective amount of (S)-oxybutynin, (S)-desethyloxybutynin or a pharmaceutically acceptable salt thereof, substantially free of the corresponding R enantiomer. Pharmaceutical compositions in the form of tablets and transdermal devices comprising (S)-oxybutynin or (S)-desethyloxybutynin and an acceptable carrier are also disclosed, as is a synthesis of desethyloxybutynin.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 14, 1997
    Assignee: Sepracor, Inc.
    Inventors: Gunnar Aberg, John R. McCullough, Yue Fang
  • Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
    Patent number: 5532278
    Abstract: A method for treating urinary incontinence while avoiding concomitant liability of adverse effects associated with racemic oxybutynin is disclosed. The method comprises administering a therapeutically effective amount of (S)-oxybutynin or a pharmaceutically acceptable salt thereof, substantially free of its R enantiomer. Pharmaceutical compositions comprising (S)-oxybutynin and an acceptable carrier are also disclosed.
    Type: Grant
    Filed: January 31, 1995
    Date of Patent: July 2, 1996
    Assignee: Sepracor, Inc.
    Inventors: Gunnar Aberg, John R. McCullough